UAE Heart Failure Treatment Drugs Market, by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and O

UAE Heart Failure Treatment Drugs Market, by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Heart failure is characterized by the inability of the heart to pump adequate amount of blood to the body. There are three types of heart failures; left-sided heart failure, right-sided heart failure, and biventricular heart failure. The condition is treated with particular cardiovascular drugs available in the market. Moreover, the treatment for heart failure depends on the stages (stage A, B, C, & D). Drugs such as diuretics, ACE inhibitors, angiotensin 2 receptor blockers, beta blockers, and digitalis are majorly used in the treatment of heart failure.

Various global players are engaged in development of novel therapies and drugs for treating heart failure. In May 2020, AstraZeneca Pharmaceuticals PLC. Received the U.S. Food and Drug Administration’s approval for Farxiga (dapagliflozin) oral tablets for adults with heart failure with reduced ejection fraction to reduce risk of cardiovascular death and hospitalization for heart failure.

Key features of the study:

  • This report provides in-depth analysis of the UAE heart failure treatment drugs market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the UAE heart failure treatment drugs market based on the following parameters – company overview, financial performance, drugs portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are Novartis International AG, AstraZeneca Plc., Amgen, Inc., Pfizer, Inc., Mylan N.V., Merck & Co., Inc., Bristol-Myers Squibb, GlaxoSmithKline Plc., and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The UAE heart failure treatment drugs market report caters to various stakeholders in this industry including investors, suppliers, drugs manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the UAE heart failure treatment drugs market.
>Detailed Segmentation
  • UAE Heart Failure Treatment Drugs Market, By Drug Class:
  • ACE Inhibitors
  • Angiotensin 2 Receptor Blockers
  • Beta Blockers
  • Diuretics
  • Aldosterone Antagonists
  • Inotropes
  • Others
  • UAE Heart Failure Treatment Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Company Profiles
  • Novartis International AG*
  • Company Overview
  • Drug Class Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • AstraZeneca Plc.
  • Amgen, Inc.
  • Pfizer, Inc.
  • Mylan N.V.
  • Merck & Co., Inc.
  • Bristol-Myers Squibb
  • GlaxoSmithKline Plc.
  • Teva Pharmaceutical Industries Ltd.
>“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Distribution Channel
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Impact Analysis
Market Opportunities
Collaborations and Acquisition
Regulatory Scenario
Pipeline Analysis
Brand Mapping and Pricing Analysis
PEST Analysis
Reimbursement Scenario
4. UAE Heart Failure Treatment Drugs Market, Impact of COVID-19 Pandemic
Overall Impact on Healthcare Market
5. UAE Heart Failure Treatment Drugs Market, By Drug Class, 2016-2027 (US$ Mn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017–2027
Segment Trends
ACE Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
Angiotensin 2 Receptor Blockers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
Beta Blockers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
Diuretics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
Aldosterone Antagonists
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
Inotropes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
6. UAE Heart Failure Treatment Drugs Market, By Distribution Channel, 2020 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017– 2027
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
7. Competitive Landscape
Company Profiles
Novartis International AG*
Company Overview
Drug Class Portfolio
Financial Overview
Key Highlights
Market Strategies
AstraZeneca Plc.
Company Overview
Drug Class Portfolio
Financial Overview
Key Highlights
Market Strategies
Amgen, Inc.
Company Overview
Drug Class Portfolio
Financial Overview
Key Highlights
Market Strategies
Pfizer, Inc.
Company Overview
Drug Class Portfolio
Financial Overview
Key Highlights
Market Strategies
Mylan N.V.
Company Overview
Drug Class Portfolio
Financial Overview
Key Highlights
Market Strategies
Merck & Co., Inc.
Company Overview
Drug Class Portfolio
Financial Overview
Key Highlights
Market Strategies
Bristol-Myers Squibb
Company Overview
Drug Class Portfolio
Financial Overview
Key Highlights
Market Strategies
GlaxoSmithKline Plc.
Company Overview
Drug Class Portfolio
Financial Overview
Key Highlights
Market Strategies
Teva Pharmaceutical Industries Ltd.
Company Overview
Drug Class Portfolio
Financial Overview
Key Highlights
Market Strategies
*Browse 06 market data tables and 16 figures on "UAE Heart Failure Treatment Drugs Market – Countrywide Forecast to 2027”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook